USHER SYNDROMES

Clinical trials for USHER SYNDROMES explained in plain language.

Never miss a new study

Get alerted when new USHER SYNDROMES trials appear

Sign up with your email to follow new studies for USHER SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill aims to slow vision loss in rare usher syndrome

Disease control Ongoing

This study tests whether an experimental tablet called NPI-001 can safely slow or stop vision loss in people with Usher syndrome, a rare genetic condition that causes blindness and hearing loss. About 49 adults will take either the drug or a placebo for 24 months. The main goal i…

Matched conditions: USHER SYNDROMES

Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 17, 2026 10:36 UTC

USHER SYNDROMES

Get alerted when new USHER SYNDROMES trials appear

New pill aims to slow vision loss in rare usher syndrome